Morocco vs Paraguay: Cause of death, by non-communicable diseases, ages 5-14
Morocco
40.7%
in 2021
Paraguay
41.2%
in 2021
Morocco rank
80th
Paraguay rank
78th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Morocco
- Paraguay
How they compare
Paraguay currently reports 41.2% against 40.7% in Morocco, a difference of 0.5%.
Across all 6 years both countries report, Paraguay has been ahead every year.
Morocco ranks 80th and Paraguay ranks 78th of 185 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Morocco | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.2% | 38.5% | 16.3% | Paraguay |
| 2010s | 38.2% | 48.2% | 10.0% | Paraguay |
| 2020s | 40.8% | 43.9% | 3.1% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Morocco or Paraguay?
- Paraguay, at 41.2% against 40.7% in Morocco as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Morocco and Paraguay?
- 0.5%, with Paraguay ahead.
- How many years of comparable data are there for Morocco and Paraguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Morocco and Paraguay rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Morocco ranks 80th and Paraguay ranks 78th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.